The Freiburg location houses the GENOVAC antibody development platform and became the second site for Aldevron in 2004. Founding partner and CEO, Michael Chambers ...

Last year, Freiburg invited some 25,000 officials and urban planners from around the world to learn from these ground-breaking projects. Thanks to this sharing of knowledge, Padua, a sister city ...